Patritumab deruxtecan (ADC)
Gecertificeerd

Patritumab deruxtecan (ADC)

Catalog #: DHD48499
Maat: 5 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Patritumab deruxtecan is an ADC consisting of a HER3-directed antibody and Dxd, a topoisomerase I inhibitor, used for the study of non-small cell lung cancer.

Product Name Alternative

HER3-DXd, U3-1287

Reactivity

Human

Applications

Research Grade Biosimilar

Stability

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.

Endotoxin

Please contact with the lab for this information.

Purity

>90% as determined by SEC.

Form

Liquid

Notes

For research use only. Not suitable for clinical or therapeutic use.

Beschrijving

Patritumab deruxtecan is an ADC consisting of a HER3-directed antibody and Dxd, a topoisomerase I inhibitor, used for the study of non-small cell lung cancer.

Specificaties

ProductnaamPatritumab deruxtecan (ADC)
Categorie
Beschikbare grootte5 mg
CatalogusnummerDHD48499